Found 413 clinical trials
Improving Well-Being for Older Adult Family Dementia Caregivers
associated with better immune function (response to current influenza vaccine), physical and emotional health, and well-being.
- 1 views
- 09 Jun, 2022
- 1 location
Influenza
This is a Phase 1 randomized study to evaluate the safety and immunogenicity of monovalent influenza modRNA vaccine (mIRV) and bivalent influenza modRNA vaccine (bIRV) at various dose levels
- 0 views
- 21 Apr, 2022
- 1 location
Influenza A Infection
Experiencing flu symptoms? We are researching the safety of an investigational medicine and to see if adding it to standard care for flu can affect how quickly patients recover.
- 103 views
- 23 Nov, 2020
- 1 location
A clinical trial for those with flu like symptoms. Must have current fever of at least 100.4 at time of screening along with flu like symptoms such as headache, tiredness, feverishness, cough, sore throat, nasal congestion. Time sensitive visits so call at first sign of illness. 314-514-8509 Monica Shutz
This time sensitive flu like illness research study is looking for subjects with a current fever of at least 100.4 at time of screening along with flu like symptoms such as headache, tiredness, feverishness, cough, sore throat, nasal congestion. Study has 4 visits and last 14 days. Time sensitive visits …
- 70 views
- 23 Nov, 2020
- 1 location
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
The primary objective of this study is:To evaluate the efficacy of fostamatinib when used in combination with standard of care (SOC) in subjects hospitalized with COVID-19 without respiratory failure and with certain high risk prognostic factors, as measured by the change in clinical status score.
- 2 views
- 10 Dec, 2021
- 35 locations
Flu Vaccine (FDA Approved) and RSV Vaccine study. - F6000
Flu Vaccine (FDA Approved) and RSV Vaccine Study. Receive up to $975 in compensation and study related care. If you are 60 years old or older you may be eligible to receive a Flu Vaccine (FDA Approved) and an RSV Vaccine at no cost. Compensation: Compensation for up to $975 …
- 0 views
- 09 Jun, 2022
- 1 location
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects with Uncomplicated Influenza
- 370 views
- 25 Mar, 2021
- 1 location
Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly with Routine Infant Vaccines to Healthy Infants
The purpose of this study is to evaluate the safety and immunogenicity of Bexsero (meningococcal group B vaccine-rMenB+OMV NZ) in North American infants 6 weeks through 12 weeks of age, when administered concomitantly with Pneumococcal conjugate vaccine (PCV 13) and other recommended routine infant vaccines (RIV).
- 0 views
- 24 Jun, 2022
- 1 location
